GlassScriptPhysician profile
William F Cox
NPI 1922047448
$986.01
in general payments reported to CMS, 2019-2025
23 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $220 · 2021: $159 · 2023: $27.90 · 2024: $224 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.65 | 2020-2024 | |
| Pfizer INC. | $90.20 | 2019-2024 | |
| Boston Scientific Corporation | $76.39 | 2024-2025 | Watchman Flx, Watchman Access System |
| Astellas Pharma US INC | $70.93 | 2019-2020 | |
| Biogen, INC. | $70.77 | 2020-2021 | |
| Cleerly, INC. | $64.84 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Novo Nordisk INC | $60.59 | 2019-2024 | |
| Glaxosmithkline, LLC. | $57.03 | 2019-2023 | Arexvy, Shingrix |
| Eisai INC. | $54.63 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.06 | 2020-2024 | Xifaxan, Trulance |
| Amgen INC. | $49.20 | 2025 | Evenity, Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $42.29 | 2019 | |
| Genentech USA, INC. | $39.55 | 2020-2021 | |
| Exact Sciences Corporation | $22.96 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $22.49 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $20.33 | 2025 | Fluad, Flucelvax |
| Renalytix Ai, INC. | $19.64 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Medtronic, INC. | $16.39 | 2024 | Venaseal |
| Lilly USA, LLC | $15.15 | 2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $14.43 | 2021 | |
| Therapeuticsmd, INC. | $11.43 | 2020 | |
| Allergan, INC. | $10.88 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.